These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6984185)

  • 1. [Role of the antiaggregation properties of the vascular wall in blood coagulation disorders].
    Baluda VP; Tamaeva TG; Gorbunova NA; Lukoianova TI; Baluda MV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):37-9. PubMed ID: 6984185
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the functional activity of thrombocytes and the antiaggregation activity of the vascular walls in regulating blood aggregation].
    Gorbunova NA; Romanova EP; Balakina TA; Agafonova EI
    Biull Eksp Biol Med; 1985 Jan; 99(1):3-4. PubMed ID: 3967067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of prostacyclin in the antiaggregation activity of the vascular wall].
    Gabrielian ES; Akopov SE; Balaian BG
    Biull Eksp Biol Med; 1984 Oct; 98(10):403-5. PubMed ID: 6388657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of adrenaline and noradrenaline on the vascular antiaggregation activity in cats].
    Gabrielian ES; Aĭvazian AG
    Farmakol Toksikol; 1986; 49(1):56-8. PubMed ID: 3948989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disordered function of the vascular-thrombocyte link in the hemostatic system during tumor growth].
    Liubina LV; Tlepshukov IK
    Biull Eksp Biol Med; 1989 Dec; 108(12):716-8. PubMed ID: 2634448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronobiology in hemodynamic imbalance syndromes and in the prevention of vascular diseases].
    Marconi G; Pappalettera N; Modoni F; Tamburrino G
    Minerva Med; 1982 Apr; 73(16):983-1046. PubMed ID: 7078794
    [No Abstract]   [Full Text] [Related]  

  • 7. [A thromboelastographic method of determining the antiaggregation activity of the vascular wall].
    Golubenkova NI; Korsun NA
    Lab Delo; 1990; (4):32-5. PubMed ID: 1695271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet release defect in a child with Ehlers-Danlos syndrome.
    Yenicesu I; Uçkan D; Soysal A; Büyükaşik Y; Gümrük F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):193-4. PubMed ID: 10734665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hematology and dentistry. Part II. Abnormalities of the vessel wall and blood platelets].
    Huijgens PC
    Ned Tijdschr Tandheelkd; 1996 Feb; 103(2):42-4. PubMed ID: 11921959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood platelet pathophysiology].
    Sixma JJ
    Ned Tijdschr Geneeskd; 1980 May; 124(21):828-33. PubMed ID: 7383201
    [No Abstract]   [Full Text] [Related]  

  • 11. [ADP-induced platelet aggregation in vascular diseases of the elderly].
    Pernigotti L; Molaschi M; Macchione C; Ferrario E; Poli L
    Minerva Med; 1981 Oct; 72(39):2617-20. PubMed ID: 7290465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alterations of blood coagulation and endothelial function in diabetic microangiopathy].
    Porta M
    Minerva Med; 1980 Jan; 71(2):119-30. PubMed ID: 6986585
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thromboresistance of vascular wall, atherogenesis, and humoral factors of thrombogenesis].
    Barkagan ES; Eremin GF
    Ter Arkh; 1981; 53(9):71-8. PubMed ID: 7302863
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous agents in platelet thrombosis.
    Born GV; Kratzer MA
    Acta Med Scand Suppl; 1981; 651():85-90. PubMed ID: 7034480
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].
    Shenkman B; Einav Y; Salomon O; Varon D; Savion N
    Platelets; 2008 Sep; 19(6):440-6. PubMed ID: 18925512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.
    Léon C; Vial C; Gachet C; Ohlmann P; Hechler B; Cazenave JP; Lecchi A; Cattaneo M
    Thromb Haemost; 1999 May; 81(5):775-81. PubMed ID: 10365753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A method of determining the antiaggregation activity of the vascular wall in man].
    Baluda VP; Lukoianova TI; Baluda MV
    Lab Delo; 1983; (6):17-20. PubMed ID: 6193313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of reserve possibilities of antiaggregation activities of the vascular wall].
    Udut VV; Naumov SA; Tiutrin II
    Lab Delo; 1989; (7):36-8. PubMed ID: 2477596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro.
    Herbert JM; Savi P
    Thromb Haemost; 1999 Jul; 82(1):156-7. PubMed ID: 10456476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.